[1]罗永苗,陈朝俊,李玥珺.基于NF-κB探讨参七脉心通胶囊抗动脉粥样硬化的作用机制[J].西部中医药,2018,31(05):8-10.
 LUO Yongmiao,CHEN Chaojun,LI Yuejun.Study on the Mechanism of ShenQi MaiXinTong Capsules Fighting against Atherosclerosis Based on NF-κB[J].Western Journal of Traditional Chinese Medicine,2018,31(05):8-10.
点击复制

基于NF-κB探讨参七脉心通胶囊抗动脉粥样硬化的作用机制()
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
31
期数:
2018年05期
页码:
8-10
栏目:
论著·临床论著
出版日期:
2018-05-15

文章信息/Info

Title:
Study on the Mechanism of ShenQi MaiXinTong Capsules Fighting against Atherosclerosis Based on NF-κB
文章编号:
1004-6852(2018)05-0008-03
作者:
罗永苗1陈朝俊2李玥珺2
1 广州中医药大学,广东 广州 510800; 2 广州市中西医结合医院脑病中心
Author(s):
LUO Yongmiao1 CHEN Chaojun2 LI Yuejun2
1 Guangzhou University of Chinese Medicine, Guangzhou 510800, China;2 Encephalopathy Center, Guangzhou Hospital of Chinese and Western Medicine
关键词:
动脉粥样硬化HDL-CLDL-CNF-κBIMT参七脉心通胶囊
Keywords:
atherosclerosis HDL-C LDL-C NF-κB IMT ShenQi MaiXinTong capsules
分类号:
R285.5
文献标志码:
A
摘要:
目的:基于NF-κB探讨参七脉心通胶囊对颈动脉粥样硬化患者硬化斑块的作用机制。方法:采用随机、对照的研究方法对比参七脉心通胶囊与辛伐他汀对动脉粥样硬化(AS)的干预作用,并观测高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、核转录因子κB(NF-κB)、颈动脉中层厚度(IMT)的变化。结果:参七脉心通胶囊可明显降低患者血清LDL-C含量,提高HDL-C水平,使LDL-C/HDL-C升高,并且可降低NF-κB水平,减少IMT。结论:参七脉心通胶囊具有类似他汀类药物调节脂质代谢的作用,可有效干预动脉粥样硬化病变、降低AS的危险性,同时可抑制NF-κB,延缓动脉粥样硬化的进展,对AS具有防治作用。
Abstract:
Objective: To explore the mechanism of ShenQi MaiXinTong capsules in treating atherosclerotic plaque of the patients with carotid atherosclerosis (AS) based on NF-κB. Methods: The effects of ShenQi MaiXinTong capsules and simvastatin in the intervention of AS were compared by using randomized controlled trials, and the changes of HDL-C, LDL-C, NF-κB and IMT were observed. Results: ShenQi MaiXinTong capsules could obviously lower the contents of LDL-C in the serum of the patients, raise the level of HDL-C, LDL-C/HDL-C, decrease the level of NF-κB and reduce IMT. Conclusion: ShenQi MaiXinTong capsules could effectively intervene AS,reduce the risk of AS, simultaneously, inhibit NF-κB and delay the progression of AS, it could prevent and treat AS, which shows the effects of statin-like drugs regulating lipid metabolism.

相似文献/References:

[1]朱晓娜,李天浩.调脂柔脉颗粒治疗动脉粥样硬化性脑梗死的疗效评价[J].西部中医药,2012,25(10):77.
 ZHU Xiao-na,LI Tian-hao.Evaluation on Clinical Efficacy of TiaoZhi RouMai Granules in Treating Atherosclerotic Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2012,25(05):77.
[2]东红.中风膏对动脉粥样硬化模型家兔血脂水平、血管内皮功能的影响*[J].西部中医药,2013,26(03):25.
 DONG Hong.Effects of ZhongFengGao on Level of Blood Fat and Vascular Endothelial Function of Rabbits with Atherosclerosis[J].Western Journal of Traditional Chinese Medicine,2013,26(05):25.
[3]张和平,谈建新,王敬敏,等.心脑通配方对大鼠颈总动脉粥样硬化斑块中MMP-2的影响[J].西部中医药,2014,27(03):32.
 ZHANG Heping,TAN Jianxin,WANG Jingmin,et al.Effects of XinNaoTong Prescription on MMP-2 in Carotid Atherosclerotic Plaque of Rats[J].Western Journal of Traditional Chinese Medicine,2014,27(05):32.
[4]王建平,梅妍△,李兰青,等.消脂胶囊对家兔代谢综合征动脉粥样硬化的影响[J].西部中医药,2016,29(03):14.
 WANG Jianping,MEI Yan,LI Lanqing,et al.Influence of XiaoZhi Capsules on Metabolic Syndrome Atherosclerosis of the Rabbits[J].Western Journal of Traditional Chinese Medicine,2016,29(05):14.
[5]张淑英,帅丽,张红芳,等.中药干预尿毒症血透患者CRP增高的临床疗效[J].西部中医药,2017,30(10):79.
 ZHANG Shuying,SHUAI Li,ZHANG Hongfang,et al.Clinical Effects of Herbs in Intervening CRP Rise of Uremia Patients with Hemodialysis[J].Western Journal of Traditional Chinese Medicine,2017,30(05):79.
[6]于妍,杨阿妮.芪乌调脂颗粒稳定大鼠动脉粥样硬化斑块的作用机制[J].西部中医药,2018,31(07):17.
 YU Yan,YANG Ani.The Mechanism of QiWu TiaoZhi Granules Stabilizing Atheroslcerotic Plaque of the Rats[J].Western Journal of Traditional Chinese Medicine,2018,31(05):17.
[7]刘云,董剑廷△.中西医结合治疗急性心肌梗死心绞痛临床观察[J].西部中医药,2019,32(01):83.
 LIU Yun,DONG Jianting.Clinical Observation on Integrative Medicine in Treating Acute Myocardial Infarction Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2019,32(05):83.
[8]聂忠富,孙小燕,张太平,等.吴茱萸碱抑制动脉粥样硬化大鼠氧化应激和炎症反应的实验研究[J].西部中医药,2019,32(08):12.
 NIE Zhongfu,SUN Xiaoyan,ZHANG Taiping,et al.Experimental Study on Rutecarpine in Inhibiting Oxidative Stress and Inflammatory Reaction of AS Rats[J].Western Journal of Traditional Chinese Medicine,2019,32(05):12.
[9]王准.通脉舒络汤治疗老年冠心病的临床观察[J].西部中医药,2020,33(06):81.[doi:10.12174/j.issn.1004-6852.2020.06.21]
 WANG Zhun.Observation on Clinical Effects of Tongmai Shuluo Tang in Treating Coronary Atherosclerotic Heart Disease in the Elderly[J].Western Journal of Traditional Chinese Medicine,2020,33(05):81.[doi:10.12174/j.issn.1004-6852.2020.06.21]
[10]马欣,李旭豪,薛玺情,等.艾灸治疗动脉粥样硬化作用机制的实验研究进展[J].西部中医药,2020,33(07):147.[doi:10.12174/j.issn.1004-6852.2020.07.40]
 MA Xin,LI Xuhao,XUE Xiqing,et al.Experimental Research on the Mechanism of Moxa-moxibustion in the Treatment of Atherosclerosis[J].Western Journal of Traditional Chinese Medicine,2020,33(05):147.[doi:10.12174/j.issn.1004-6852.2020.07.40]

备注/Memo

备注/Memo:
收稿日期:2017-11-06 *基金项目:广东省省级科技计划项目(编号2013B022000026)。 作者简介:罗永苗(1991—),女,在读硕士研究生。研究方向:神经内科疾病的中西医结合诊治。
更新日期/Last Update: 2018-05-15